SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C164 - Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies

Event Time: Wednesday April 26, 2017 1:00 pm to 3:00 pm
Topic(s): Neuromuscular and Clinical Neurophysiology (EMG)
Director(s): Amanda Peltier MD, MS
Description: Availability of noninvasive autonomic testing is expanding neurologic practice in the diagnosis and management of disorders of the autonomic nervous system. Faculty will provide a clinical overview of autonomic tests, and clinical approaches to common autonomic disorders and their diagnosis. This program complements C180: Evaluation and Management of Autonomic Disorders II, but covers independent topics.
Completion Message: Participants should be able to improve their ability to formulate a differential diagnosis, organize a work-up, and a treatment plan for patients with autonomic dysfunction.
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
1:00 PM - 1:40 PM Autonomic Testing: Where Is the Lesion Wolfgang Singer MD 
1:40 PM - 2:10 PM Autonomic Synucleinopathies Horacio Kaufmann MD, FAAN 
2:10 PM - 2:40 PM Autonomic Peripheral Neuropathies Roy Freeman MD 
2:40 PM - 3:00 PM Questions and Answers Faculty 

Disclosures

Speaker Disclosure
Roy L. Freeman, MD Dr. Freeman has received personal compensation for activities with Abide, Astellas, Biogen, Daiichi-Sankyo, Grunental, Lundbeck, Nestkem Novartis, Pfizer as a member of a scientific advisory board. Dr. Freeman has received personal compensation in an editorial capacity for Autonomic Neuroscience. Dr. Freeman has received research support from Pfizer and Astra-Zeneca.

Horacio C. Kaufmann, MD, FAAN Dr. Kaufmann received personal compensation from Lundbeck and Astra Zeneca for his membership on Scientific Advisory Board.. Dr. Kaufmann received personal compensation from Springer for serving as editor in Chief of Clinical Autonomic Research.. Dr. Kaufmann received support for conducting clinical trials of Droxidopa for Chelsea Therapeutics..

Wolfgang Singer, MD DSMB member for Actinogen and SunPharma.

Register Now

Related Courses

Sunday April 22, 2018

7:00 AM-9:00 AM
C30 Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies Michael Shy MD
1:00 PM-3:00 PM
C40 Peripheral Neuropathy II: Diabetic and Inherited Neuropathies Michael Shy MD
1:00 PM-5:30 PM
C47 Neuromuscular Ultrasound Skills Workshop (Registration Required) Craig Zaidman MD
3:30 PM-5:30 PM
C54 Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing Michael Shy MD

Tuesday April 24, 2018

1:00 PM-5:30 PM
C118 EMG Skills Workshop: Basic Ezgi Tiryaki MD, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C141 Mastering EMG Waveform Recognition Skills in Just Two Hours! Devon Rubin MD, FAAN
1:00 PM-3:00 PM
C154 Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System Christopher Gibbons MD, FAAN
3:30 PM-5:30 PM
C168 Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System Christopher Gibbons MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C178 Clinical EMG I: Principles and Practice of NCS and Needle EMG Ruple Laughlin MD, FAAN
1:00 PM-3:00 PM
C191 Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG Mark Bromberg MD, PhD, FAAN
3:30 PM-5:30 PM
C205 Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Mark Bromberg MD, PhD, FAAN
6:30 PM-9:30 PM
C209 Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease Anne Connolly MD, FAAN

MEMBER LOG IN

Forgot Password?